Chronic Migrane research hub

Interventional, randomized, double-blind, parallel-group, placebo-controlled study of add-on eptinezumab treatment to brief education intervention, for the preventive treatment of migraine in patients with a dual diagnosis of migraine and Medication Overuse Headache.

This study looks at a medicine called VYEPTI for people who get frequent migraines and also over-use headache pain relievers. It compares VYEPTI plus headache education to a dummy treatment plus education, to see if VYEPTI helps reduce headache days.